Indeed, an impairment of TGF-β1 has been demonstrated in the AD brain and serum17 and a nucleotide polymorphism of the TGF-β1 gene has been associated with an increased conversion of mild cognitive impairment in AD and with an increased risk to develop Late-Onset AD27. The gene discussed is TGFB1; the disease is Cognitive impairment.